Neurobionics Raises $5M Seed Funding for Advanced Neuromodulation Technology

Neurobionics has secured a $5 million seed funding round, exceeding expectations and demonstrating strong investor confidence in the company’s innovative endovascular neuromodulation technology. This investment will propel the development of this groundbreaking technology which aims to deliver significant advancements in medical treatment options across various fields. The oversubscribed round reflects the growing demand for advanced technologies capable of improving patient outcomes.